Author: admin_7b3Rwhh

The alliance is aimed at developing treatments for Parkinson’s and another neurodegeneration indication

The doctor of nursing practice specialized in movement disorders discussed specific data the StrivePD app captures and how it can enhance quality of life for patients with Parkinson disease. [WATCH TIME: 3 minutes]

Therapy shows high efficacy in initial trial phase

Magnetic fields to control neurons remotely? A cutting-edge technology, magnetogenetics, now allows the inhibition or…

The Parkinson’s Group makes life better for people with Parkinson’s disease.

The Parkinson’s Group makes life better for people with Parkinson’s disease.

Dexys Midnight Runners’ founding member Andy Leek has died following a lengthy battle with Parkinson’s disease, his wife has announced.

The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs), says data and analytics company GlobalData in an overview of ongoing PD research..
With current treatments largely focused on motor symptoms, the pipeline across the seven major markets (7MM) highlights a growing emphasis on DMTs and non-motor symptom therapies, according to GlobalData.

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson’s patients.